The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 112.50
Bid: 110.00
Ask: 115.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.545%)
Open: 112.50
High: 114.00
Low: 112.50
Prev. Close: 112.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Regulatory Approval

22 Jan 2018 07:00

ECO Animal Health Group plc

(AIM: EAH)

ECO RECEIVES UKRANIAN MARKETING AUTHORISATIONS FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a number of marketing authorisations for Aivlosin® from the Department for Food Safety and Veterinary from the State Service of Ukraine on Food Safety and Consumer Protection.

Aivlosin ® , ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

These authorisations, which are for the use of Aivlosin® 625 mg/g water soluble granules and Aivlosin® 42.5 mg/g premix for both pigs and poultry, also allow ECO to start selling Aivlosin® in the Ukraine for the medication of drinking water or for mixing into feed, for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption, with a zero day drug withdrawal period for eggs.

These new treatments meet all the guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, these treatments are under the control of veterinarians, available under prescription only and have low, highly effective therapeutic dose rates, a short treatment duration and a zero day or very short drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive these marketing authorisations for Aivlosin® in the Ukraine, the sixteenth largest egg producing country and one that is ranked just outside the top twenty globally for pork production.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence   020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
 

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders

View source version on businesswire.com: http://www.businesswire.com/news/home/20180121005079/en/

Copyright Business Wire 2018

Date   Source Headline
2nd Aug 20191:12 pmBUSCirc re. Posting of Annual Report 2019
1st Aug 20192:17 pmBUSDirector/PDMR Shareholding
1st Aug 20197:00 amBUSBlock listing Interim Review
1st Aug 20197:00 amBUSTotal Voting Rights
8th Jul 20198:23 amBUSHolding(s) in Company
3rd Jul 20197:59 amBUSHolding(s) in Company
19th Jun 20197:00 amBUSFinal Results
5th Jun 201912:43 pmBUSHolding(s) in Company
29th May 20193:13 pmBUSDoc re. Change of Director Responsibilities
2nd Apr 20197:00 amBUSRegulatory Approval
20th Mar 20197:00 amBUSHolding(s) in Company
7th Mar 20197:05 amBUSDirector/PDMR Shareholding
7th Mar 20197:00 amBUSDirectorate change
5th Mar 20197:00 amBUSRegulatory Approval
13th Feb 20197:00 amBUSStatement Re ECO Animal Health and Ghent University Sign Poultry Vaccine Development Licencing Deal
7th Feb 201911:50 amBUSDirector/PDMR Shareholding
5th Feb 20199:58 amBUSHolding(s) in Company
5th Feb 20197:00 amBUSStatement re ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal
1st Feb 20197:00 amBUSTotal Voting Rights
1st Feb 20197:00 amBUSBlock listing Interim Review
31st Jan 201911:14 amBUSHolding(s) in Company
16th Jan 201910:48 amBUSDirector/PDMR Shareholding
27th Dec 20187:19 amBUSHolding(s) in Company
13th Dec 20183:00 pmBUSHolding(s) in Company
10th Dec 20187:00 amBUSHalf-year Report
5th Dec 201810:31 amBUSHolding(s) in Company
3rd Dec 20187:00 amBUSStatement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal
27th Nov 20189:32 amBUSNotice of Results
19th Nov 20187:00 amBUSStatement re Joint poultry vaccine development licencing deal
7th Nov 20187:00 amBUSRegulatory Approval
1st Nov 20183:40 pmBUSHolding(s) in Company
1st Nov 20183:01 pmBUSHolding(s) in Company
26th Oct 20187:48 amBUSDirector/PDMR Shareholding
16th Oct 201811:26 amBUSHolding(s) in Company
20th Jul 20182:09 pmBUSDirector/PDMR Shareholding
18th Jul 201810:06 amBUSHolding(s) in Company
18th Jul 201810:01 amBUSHolding(s) in Company
10th Jul 20188:58 amBUSHolding(s) in Company
3rd Jul 20189:05 amBUSHolding(s) in Company
3rd Jul 20189:03 amBUSHolding(s) in Company
2nd Jul 20181:16 pmBUSDoc re. Block Listing Admission
2nd Jul 20187:00 amBUSFinal Results
1st May 20188:37 amBUSTotal Voting Rights
24th Apr 201811:22 amBUSHolding(s) in Company
12th Apr 201810:16 amBUSDirector/PDMR Shareholding
11th Apr 201812:03 pmBUSDirector/PDMR Shareholding
5th Apr 201812:02 pmBUSDirector/PDMR Shareholding - Replacement
5th Apr 201810:44 amBUSDirector/PDMR Shareholding
3rd Apr 20187:00 amBUSJoint Venture
5th Mar 20187:00 amBUSRegulatory Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.